|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MARTEK BIOSCIENCES CORP, 10-Q, 2000-09-14 |
Next: MARTEK BIOSCIENCES CORP, 10-Q, EX-99, 2000-09-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> OCT-31-2000
<PERIOD-START> NOV-01-1999
<PERIOD-END> JUL-31-2000
<CASH> 4,631,434
<SECURITIES> 19,450,628
<RECEIVABLES> 2,738,910
<ALLOWANCES> 9,626
<INVENTORY> 4,383,361
<CURRENT-ASSETS> 31,882,853
<PP&E> 23,262,869
<DEPRECIATION> 7,546,715
<TOTAL-ASSETS> 47,599,007
<CURRENT-LIABILITIES> 5,878,969
<BONDS> 0
0
0
<COMMON> 1,779,375
<OTHER-SE> 39,269,074
<TOTAL-LIABILITY-AND-EQUITY> 47,599,007
<SALES> 5,415,621
<TOTAL-REVENUES> 6,607,267
<CGS> 4,506,931
<TOTAL-COSTS> 19,065,570
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 180,325
<INCOME-PRETAX> (11,672,229)
<INCOME-TAX> 0
<INCOME-CONTINUING> (11,672,229)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (11,672,229)
<EPS-BASIC> (.68)
<EPS-DILUTED> (.68)
</TABLE>
|
|